Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 1,09,180 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 ( JPL ESOP 2022 ) ''.'.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On January 6, 2026, Jagsonpal Pharmaceuticals allotted 1,09,180 equity shares (face value Rs. 2 each) to eligible employees under its Employee Stock Option Plan 2022, after they exercised their vested stock options. The exercise price was Rs. 94 per share for 1,05,200 shares and Rs. 115.60 per share for 3,980 shares, both at a premium over face value. As a result, the company's paid-up share capital rose from Rs. 13.36 crore to Rs. 13.38 crore, with total equity shares increasing from 6,67,81,270 to 6,68,90,450. The newly issued shares will rank equally with existing shares in all respects, and no lock-in period applies. This is a routine ESOP exercise disclosure, not a fresh capital raise from the market.
Minor dilution of about 0.16% for existing shareholders due to the share issuance. The allotment is from an existing employee benefit plan, so it does not bring in new capital from the market and is unlikely to materially affect the stock price.